Punit S. Dhillon - 10 Nov 2022 Form 4 Insider Report for Arch Therapeutics, Inc. (ARTHQ)

Reporting relationship: Director
Issuer ticker: ARTHQ
Reported as of: 10 Nov 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Nov 2022, 20:54:22 UTC
Prior SEC filing: 16 Dec 2021
Next SEC filing: 31 Aug 2023
Source filing: View source filing
Reporting owner signature: /s/ Punit Dhillon

Key filing fact

Punit S. Dhillon filed Form 4 for Arch Therapeutics, Inc. (ARTHQ) on 10 Nov 2022.

Key facts

This page summarizes Punit S. Dhillon's Form 4 filing for Arch Therapeutics, Inc. (ARTHQ).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Nov 2022, 20:54.

Change

Previous filing in this sequence was filed on 16 Dec 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ARTH transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +250,000
Change %
Price: $0.000000
Shares after: 250,000
Date: 10 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 250,000
Exercise price: $0.0401
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option was granted pursuant to the Issuer's 2013 Stock Incentive Plan (the "Plan"). The option shall vest equally on each of the first 12 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable.